NVS (NVS) Stock Analysis

NVS (NVS) is a publicly traded company in the HEALTHCARE sector. It trades at $143.48, carries a market capitalization of $277.97B, a price-to-earnings ratio of 20.87, a dividend yield of 0.03%. This page summarizes the public market data, fundamentals, and frequently asked questions for NVS, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DRUG MANUFACTURERS - GENERAL

Exchange: NYSE

Key Metrics

• Price: $143.48
• Market Cap: $277.97B
• P/E Ratio: 20.87
• EPS: $6.98
• Dividend Yield: 0.03%
• 52-Week High: $165.43
• 52-Week Low: $109.02

Market Sentiment

NVS currently has a Bullish sentiment score of 0.23.

About NVS

Novartis AG (ADR) is a premier global healthcare company headquartered in Basel, Switzerland, dedicated to the research, development, manufacturing, and marketing of innovative pharmaceuticals and medical devices. Renowned for its robust portfolio of patented treatments across critical therapeutic areas such as oncology, cardiology, and immunology, Novartis leverages cutting-edge science to enhance patient outcomes. The company's strong focus on research and development, along with strategic ...

GNG Research Analysis

GNG Research scores NVS (NVS) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for NVS.

Frequently Asked Questions

What is NVS's current dividend yield?

NVS (NVS) has a current dividend yield of 0.03%.

Does NVS pay dividends?

Yes, NVS pays dividends with a current yield of 0.03%.

What is NVS's P/E ratio?

NVS has a price-to-earnings (P/E) ratio of 20.87.

What is NVS's market cap?

NVS (NVS) has a market capitalization of $277.97B with a current stock price of $143.48.